Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S.
Please provide your email address to receive an email when new articles are posted on . FDA approved semaglutide to lower the risk for worsening kidney disease, kidney failure and CV death in type 2 ...
On 21 October 2019, the European Medicines Agency (EMA) published a guide for assessors of centralised applications for marketing authorisation. The guide focuses on the wording used in therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results